<DOC>
	<DOCNO>NCT01071746</DOCNO>
	<brief_summary>Patients acute chronic liver failure risk develop multiorgan failure high mortality . The current score system define outcome patient acute decompensation cirrhosis fail identify patient progress Acute-on-chronic liver failure ( ACLF ) . The aim study evaluate one identify patient early propose biomarkers : dimethylarginines ischemia modify albumin .</brief_summary>
	<brief_title>Predictive Utility DASIMAR Prognostic Biomarker Acute-on-chronic Liver Failure ( ACLF )</brief_title>
	<detailed_description>Patients acute-on-chronic liver failure ( ACLF ) risk multiorgan failure high mortality . Recent data suggest patient decompensated liver cirrhosis high ADMA ( asymmetrical dimethylarginine ) level compare compensated cirrhosis plasma ADMA level correlate severity liver dysfunction inflammation . There also increase symmetric dimethylarginine ( SDMA ) , stereo-isomer ADMA , largely excreted kidney . Plasma SDMA level show associated patient progress renal failure . In pilot study group involve 52 patient acute decompensation chronic liver disease , show increase sum product ADMA SDMA , term dimethylarginine score ( 'DAS ' ) : This show good predictive utility outcome small group patient ( AUROC=0.89 ) . Furthermore , others show albumin patient advance liver disease widespread abnormality . The amount albumin find reduce metal bind capacity consequence oxidative damage term Ischemia Modified Albumin ( IMA ) . Our data show patient ACLF die significantly increase IMA/serum albumin ratio ( IMAR ) . The summation two pathologically relevant biomarkers ( DAS+IMAR ) term DASIMAR find score well predictive utility DAS alone ( AUROC:0.91 ) . Primary objective : To identify patient early progress ACLF would facilitate goal direct therapeutic approach . Secondary objective : Generation dataset define enable prognostication ACLF . If study reveals role biomarkers patient ACLF , commercial development simple kit may possible .</detailed_description>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<criteria>All patient acute clinical decompensation presume cirrhosis ( elevate bilirubin &gt; 85 Âµmol/L , or/and increase ascites or/and hepatic encephalopathy &lt; grade 2 ) relate clear precipitate event ( e.g . infection , bleeding , alcoholic hepatitis , exposure hepatotoxin ) Admission reason decompensation cirrhosis ( comorbid disease , especially establish cardiovascular renal disease ( U/S ) . Malignancy ( extrahepatic hepatocellular carcinoma ) . Patients undergone major surgery unsolved surgical problem . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>